Background Retarded growth in utero has been linked with high blood pr
essure and other risk factors for cardiovascular disease in adult life
. However, the influence on fetal growth of the maternal blood pressur
e during pregnancy is not well defined. In a prospective study, we exa
mined the relation between maternal ambulatory blood pressure during p
regnancy and indices of fetal growth. Methods We studied 209 healthy n
ulliparous pregnant women referred to an inner-city district general h
ospital (86% of 244 consecutively referred women who met the study cri
teria). 24 h ambulatory blood-pressure recordings were obtained in ear
ly (median 18 weeks [IQR 17-18]) mid (28 weeks [28]), and late (36 wee
ks [36]) gestation. Eight infants delivered before 32 weeks' gestation
were excluded from the analysis. Findings A 5 mm Hg (1 SD) increase i
n mean 24 h diastolic blood pressure at 28 weeks' gestation was associ
ated with a 68 g (95% CI 3-132) decrease in birthweight; a similar cha
nge in diastolic pressure at 36 weeks' gestation was associated with a
76 g (24-129) decrease in birthweight. These associations were indepe
ndent of potential confounders (maternal age, height, weight, cigarett
e smoking, alcohol intake, ethnic origin, pregnancy hypertension syndr
omes, and preterm birth). Maternal mean 24 h diastolic blood pressure
at 28 weeks' gestation was also inversely associated with the infant's
ponderal index at birth in multivariate analysis (p=0.06). Higher mat
ernal ambulatory blood pressure at 28 weeks' and 36 weeks' gestation a
lso predicted lower head circumference, although these associations we
re dependent on birthweight. Associations between ambulatory systolic
blood pressure and indices of fetal growth were weak and inconsistent
and ambulatory blood pressure at 18 weeks' gestation did not predict f
etal growth. Interpretation There is a continuous inverse association
between fetal growth and maternal blood pressure, throughout the range
seen in normal pregnancy. Maternal blood pressure may be an important
confounding factor in the reported associations between fetal growth
retardation and adult hypertension and cardiovascular disease.